Cargando…

Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia

CD81 is a cell surface protein which belongs to the tetraspanin family. While in multiple myeloma its expression on plasma cells is associated with worse prognosis, this has not yet been explored in acute myeloid leukemia (AML). We measured membrane expression of CD81 on AML cells at diagnosis, eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boyer, Thomas, Guihard, Soizic, Roumier, Christophe, Peyrouze, Pauline, Gonzales, Fanny, Berthon, Céline, Quesnel, Bruno, Preudhomme, Claude, Behal, Hélène, Duhamel, Alain, Roche-Lestienne, Catherine, Cheok, Meyling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308734/ https://www.ncbi.nlm.nih.gov/pubmed/27566555 http://dx.doi.org/10.18632/oncotarget.11481

Ejemplares similares

Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study
por: Boyer, Thomas, et al.
Publicado: (2019)

B7‐H3 protein expression in acute myeloid leukemia
por: Guery, Thomas, et al.
Publicado: (2015)

CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
por: Touzet, Lucas, et al.
Publicado: (2019)

Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment
por: Fenwarth, Laurène, et al.
Publicado: (2020)

A 17-gene-expression profile to improve prognosis prediction in childhood acute myeloid leukemia
por: Duployez, Nicolas, et al.
Publicado: (2018)

Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex Karyotype
por: Fenwarth, Laurène, et al.
Publicado: (2019)

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association
por: Debarri, Houria, et al.
Publicado: (2015)

Impact of CNA on AML prognosis
por: Gonzales, Fanny, et al.
Publicado: (2017)

Involvement of ORAI1/SOCE in Human AML Cell Lines and Primary Cells According to ABCB1 Activity, LSC Compartment and Potential Resistance to Ara-C Exposure
por: Lewuillon, Clara, et al.
Publicado: (2022)

Tetraspanin CD81 regulates HSV-1 infection
por: Benayas, Beatriz, et al.
Publicado: (2020)

GILZ inhibits the mTORC2/AKT pathway in BCR-ABL(+) cells
por: Joha, S, et al.
Publicado: (2012)

Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone size
por: Berthon, Celine, et al.
Publicado: (2020)

Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study
por: Ceraulo, Antony, et al.
Publicado: (2022)

The Tetraspanin CD81 Is a Host Factor for Chikungunya Virus Replication
por: Lasswitz, Lisa, et al.
Publicado: (2022)

LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study
por: Vasseur, Loïc, et al.
Publicado: (2023)

Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes
por: Takeda, Yoshito, et al.
Publicado: (2003)

Application of tetraspanin CD81 RNAi for diagnosis and therapy of rheumatoid arthritis (RA)
por: Nakanishi, Tohru, et al.
Publicado: (2012)

The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry
por: Rocha-Perugini, Vera, et al.
Publicado: (2009)

A role for the tetraspanin CD81 on the late steps of HIV-1 replication in T-lymphoblastic cells
por: Muriaux, Delphine
Publicado: (2010)

A new panel of epitope mapped monoclonal antibodies recognising the prototypical tetraspanin CD81
por: Grove, Joe, et al.
Publicado: (2017)

Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases
por: Bailly, Christian, et al.
Publicado: (2023)

Hereditary Predisposition to Acute Myeloid Leukemia in Older Adults
por: Fenwarth, Laurène, et al.
Publicado: (2021)

Green Synthesis, Experimental and Theoretical Studies to Discover Novel Binders of Exosomal Tetraspanin CD81 Protein
por: Anand, Krishnan, et al.
Publicado: (2020)

Mycobacterium abscessus alkyl hydroperoxide reductase C promotes cell invasion by binding to tetraspanin CD81
por: Karam, Jona, et al.
Publicado: (2023)

Screening of EWI-2-Derived Peptides for Targeting Tetraspanin CD81 and Their Effect on Cancer Cell Migration
por: Suwatthanarak, Thanawat, et al.
Publicado: (2023)

The CD9/CD81 Tetraspanin Complex and Tetraspanin CD151 Regulate α3β1 Integrin-Dependent Tumor Cell Behaviors by Overlapping but Distinct Mechanisms
por: Gustafson-Wagner, Elisabeth, et al.
Publicado: (2013)

High-Level Expression, Single-Step Immunoaffinity Purification and Characterization of Human Tetraspanin Membrane Protein CD81
por: Takayama, Hidehito, et al.
Publicado: (2008)

The Tetraspanins CD9 and CD81 Regulate CD9P1-Induced Effects on Cell Migration
por: Chambrion, Célia, et al.
Publicado: (2010)

Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging
por: Jin, Yingji, et al.
Publicado: (2018)

Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial
por: Renneville, Aline, et al.
Publicado: (2014)

BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia
por: Herbaux, Charles, et al.
Publicado: (2016)

A dynamic interaction between CD19 and the tetraspanin CD81 controls B cell co-receptor trafficking
por: Susa, Katherine J, et al.
Publicado: (2020)

Bimodal expression of RHOH during myelomonocytic differentiation: Implications for the expansion of AML differentiation therapy
por: Galiègue‐Zouitina, Sylvie, et al.
Publicado: (2021)

UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia
por: Duployez, Nicolas, et al.
Publicado: (2023)

In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53
por: Deneka, Magdalena, et al.
Publicado: (2007)

Targeting the Tetraspanins with Monoclonal Antibodies in Oncology: Focus on Tspan8/Co-029
por: Bonnet, Mathilde, et al.
Publicado: (2019)

TETRASPANINs in Plants
por: Reimann, Ronny, et al.
Publicado: (2017)

Small extracellular vesicles have distinct CD81 and CD9 tetraspanin expression profiles in plasma from rheumatoid arthritis patients
por: Rydland, Anne, et al.
Publicado: (2023)

In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors
por: Berthon, Céline, et al.
Publicado: (2010)

Clinically Relevant Oxygraphic Assay to Assess Mitochondrial Energy Metabolism in Acute Myeloid Leukemia Patients
por: Fovez, Quentin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l0hdn4n880fn1ps6j0ncutnjae